Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
LOXO-338 by Loxo Oncology for B-Cell Chronic Lymphocytic Leukemia: Likelihood of Approval
LOXO-338 is under clinical development by Loxo Oncology and currently in Phase I for B-Cell Chronic Lymphocytic Leukemia. According to...